Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -5.51% | 4.21bn |
Karuna Therapeutics Inc | -3.61% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -11.77% | 350.00m |
Mirati Therapeutics Inc | -12.80% | 5.12bn |
Data delayed at least 15 minutes, as of Sep 21 2024 00:00 BST.
Holder | Shares | % Held |
---|---|---|
Credit Suisse Asset Management (Schweiz) AGas of 31 Dec 2023 | 32.30k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 May 2024 | 4.63k | 0.00% |
Data from 31 May 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.